ArticleCardio-oncology (London, England)2026
Unveiling temporal trends and disparities in mortality with co-listed coronary artery disease and cancer, 1999-2024: insights from the CDC WONDER multiple cause of death database.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary artery disease (CAD) remains one of the primary causes of morbidity and mortality worldwide. Although cancer mortality rates have declined in many high-income countries, including the United States, substantial variability persists. This study aimed to assess the trends and disparities in mortality among adults with co-listed CAD and cancer on death certificates.
methodsWe conducted a retrospective analysis using the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) Multiple Cause-of-Death database. Data were extracted for co-listed CAD and cancer spanning from 1999 to 2024. Age adjusted mortality rates (AAMRs) were calculated. The Joinpoint Regression Program was used to evaluate annual percentage changes (APC) and average annual percentage change (AAPC) with 95% confidence intervals (CI).
resultsOver 26 years, 1,321,891 deaths occurred with co-listed CAD and cancer. The overall AAMR decreased from 31.38 in 1999 to 19.77 in 2024 (AAPC: -1.88, 95% CI: -2.01 to -1.77). Men had higher mean AAMRs (36.86) than women (13.93). Among races, the highest mean AAMRs were observed in Non-Hispanic (NH) White (23.84), and NH Black (22.1), followed by NH American Indian or Alaskan Native (15.28), Hispanic (14.00), and NH Asian or Pacific Islander (11.44) individuals. Regionally, the Midwest showed higher mean AAMR (25.21), then Northeast (24.88), South (21.93), and West (21.33). Age group categorization showed highest mean AAMR in older adults (107.05), followed by middle-aged adults (6.35), and younger adults (0.18). Stratified by urbanization, rural areas exhibited higher mean AAMR (27.58) compared to urban areas (22.92). Among states, the highest mortality rates were observed in West Virginia (35.86).
conclusionThe AAMR for co-listed CAD and cancer has decreased from 1999 to 2024, with significant disparities persisting in demographics and different regions. These disparities highlight the need for targeted, equitable public health interventions to reduce mortality in these vulnerable populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.